Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

SIGNIFICANT ACCOUNTING POLICIES - Disclosure of detailed information about subsidiaries (Details)

v3.21.1
SIGNIFICANT ACCOUNTING POLICIES - Disclosure of detailed information about subsidiaries (Details)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
I.M.C. Holdings Ltd ("IMC") [Member]    
Disclosure of subsidiaries [line items]    
Percentage ownership 100.00% 100.00%
Focus Medical Herbs Ltd. ("Focus") [Member]    
Disclosure of subsidiaries [line items]    
Percentage ownership 74.00% 74.00%
I.M.C Farms Israel Ltd. ("IMC Farms") [Member]    
Disclosure of subsidiaries [line items]    
Percentage ownership 100.00% 100.00%
I.M.C Ventures Ltd. ("IMC Ventures") [Member]    
Disclosure of subsidiaries [line items]    
Percentage ownership 75.00% 75.00%
I.M.C - International Medical Cannabis Portugal Unipessoal Lda [Member]    
Disclosure of subsidiaries [line items]    
Percentage ownership 100.00% 100.00%
Adjupharm GmbH ("Adjupharm") [Member]    
Disclosure of subsidiaries [line items]    
Percentage ownership 92.50% 95.00%